200 related articles for article (PubMed ID: 36402232)
21. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
22. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.
Wang F; Liao W; Li C; Zhu L
Int Immunopharmacol; 2024 Jun; 134():112187. PubMed ID: 38733825
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
24. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370
[TBL] [Abstract][Full Text] [Related]
25. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
26. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
[TBL] [Abstract][Full Text] [Related]
27. Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression.
Li H; Yang C; Wei Y; Li X; Jiang W; Xu Y; Li L; Guo R; Chen D; Gao P; Zhang H; Qin H; Zhang Z; Liu X; Yan D
Theranostics; 2023; 13(11):3794-3813. PubMed ID: 37441589
[No Abstract] [Full Text] [Related]
28. Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-κB in glioma.
Bai J; Zhang X; Meng W; Xu H; Liu Y; Zhong Y; Lin X; Wang J; Fan D; Lv G; Gu Y
Phytomedicine; 2024 Jun; 128():155417. PubMed ID: 38518642
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
30. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
32. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
[TBL] [Abstract][Full Text] [Related]
33. HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1.
He ZC; Liu Q; Yang KD; Chen C; Zhang XN; Wang WY; Zeng H; Wang B; Liu YQ; Luo M; Li L; Niu Q; Lu HM; Luo T; Yao XH; Guo HT; Ji JL; Cao MF; Shi Y; Ping YF; Bian XW
Cancer Lett; 2022 May; 533():215605. PubMed ID: 35219772
[TBL] [Abstract][Full Text] [Related]
34. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.
Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A
Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386
[TBL] [Abstract][Full Text] [Related]
35. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
[TBL] [Abstract][Full Text] [Related]
36. BACH1 as a potential target for immunotherapy in glioblastomas.
Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
[TBL] [Abstract][Full Text] [Related]
37. Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma.
Batchu S; Hanafy KA; Redjal N; Godil SS; Thomas AJ
Sci Rep; 2023 Nov; 13(1):20874. PubMed ID: 38012322
[TBL] [Abstract][Full Text] [Related]
38. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
39. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
40. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH
PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
